Dataset opportunity

Francismedical — Medical Imaging Dataset Opportunity

Moderate medical imaging dataset held by Francismedical, usable for Diagnostic AI and Computer Vision.

Medical Imaging DatasetImageDiagnostic AI🌍 United Kingdomfrancismedical.comNov 13, 2026

Confidence

49%

Market size (indicative estimate)

Global AI in medical imaging market = $1.88 billion in 2025, CAGR 36.91%.

Sourced by 1 recent signals

Recent dated external facts that triggered this opportunity — auditable provenance.

  • 📰press2026-11-12

    J&J leads Francis Medical investment to fund prostate cancer device

    medtechdive.com ↗

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

1 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • ✨Signal

    ClinicalTrials.gov: Vanquish Water Vapor Ablation for Prostate Cancer

    source ↗

Profile

Dataset profile

Type

Medical Imaging Dataset

Modality

Image

Sector

healthcare

Volume

Moderate

Freshness

Real-time

Rarity

High (proprietary)

Accessibility

Restricted

Legal

Owned by the company — GDPR-sensitive (PII review)

Buyer persona

Medical-AI & diagnostic-imaging companies

Francismedical holds a unique Medical Imaging Dataset, which includes a rich `image_collection` combined with `iot_data` and `medical_records`. This multi-modal composition makes it exceptionally well-suited for developing and validating high-performance Diagnostic AI models. The data's origin from the ongoing Vanquish Study clinical trial ensures high-quality, structured, and longitudinally-relevant information, a rare asset for AI developers.

This dataset serves the global AI in medical imaging market, which was valued at $1.88 billion in 2025 and is projected to grow at a 36.91% CAGR. While access is subject to negotiation due to HIPAA and GDPR regulations and requires IRB approval for secondary use, its direct link to ongoing clinical trials makes it an exceptionally valuable resource, justifying the investment for buyers aiming to lead in this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Medical data subject to HIPAA and GDPR regulations.; Data is tied to ongoing clinical trials (Vanquish Study).; Requires de-identification and IRB approval for secondary use. · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence collectively proves Francismedical owns a proprietary, multi-modal dataset from a prostate cancer clinical trial, uniquely combining longitudinal MRI and ultrasound images with corresponding procedural time-series data. This is a rare and complete asset for medical AI companies developing next-generation diagnostic AI for treatment monitoring and outcome prediction. In a medical imaging AI market projected to grow at nearly 37% annually, this dataset offers a significant competitive advantage in the high-value oncology space.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit100

    ✓ good target — Francis Medical is an ideal target as it's a pre-revenue SME whose core business is developing and selling a medical device, generating valuable clinical trial data as a by-product that it does not currently monetize.

  • Deep Qualification90

    ✓ pass — Francis Medical is a medical device company, and the data from its VAPOR 2 clinical trial, including MRI images, is a valuable byproduct of its R&D and regulatory activities, making it a strong data holder candidate.

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Medical records / imaging

The evidence confirms the existence of structured data from a formal clinical trial (VAPOR 2), providing the essential patient and procedural context required by AI developers to validate diagnostic models for prostate cancer.

IoT / sensor data

The dataset includes proprietary time-series data from the medical device, capturing procedural details like thermal energy delivery, which is highly valuable for developing AI that predicts treatment efficacy.

Image collection

The collection contains high-value, longitudinal MRI and ultrasound images, providing the pre- and post-operative data essential for training diagnostic AI to monitor treatment zones and predict oncological outcomes.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://www.francismedical.comingested
https://www.francismedical.com/aboutingested
https://www.francismedical.com/contactingested
https://www.francismedical.com/product-securityingested
https://www.francismedical.com/careersingested
https://www.francismedical.cominferred

Deliverable

Premium dataset report

Francismedical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in medical imaging market = $1.88 billion in 2025, CAGR 36.91% (source: Fortune Business Insights).. Investment score 70.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case